M2T-CD33

N/A

Report date: 2025/11/10 15:23:41

Base Information

Drug NameM2T-CD33
Drug Alias NameM2T-CD33LTI-214
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHistocompatibility antigens class II modulators
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeukogene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeukogene Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A